NCT05870449 (PICC) is a NA clinical trial of tunneled PICC in Cancer, sponsored by Shandong Branden Med.Device Co.,Ltd.

Who is sponsoring NCT05870449?

NCT05870449 is sponsored by Shandong Branden Med.Device Co.,Ltd.

What drugs are being tested in NCT05870449?

Interventions in NCT05870449: tunneled PICC, routine PICC.

What condition does NCT05870449 study?

NCT05870449 studies Cancer, Thrombus, Phlebitis, Infections.

Is NCT05870449 still recruiting?

NCT05870449 is currently status unknown. Last updated 23 May 2023.

Last reviewed 2023-05-23 · How we verify

NCT05870449: PICC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Impact of Climate Environment in Different Latitudes on the Occurrence of PICC Complications

Status unknown NA Last updated 23 May 2023

What this trial tests

NA trial testing tunneled PICC in Cancer in 1,666 participants. Status unknown.

Timeline

1 July 2023

Primary endpoint
1 July 2024

31 December 2024

Quick facts

Lead sponsor	Shandong Branden Med.Device Co.,Ltd
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	1,666
Start date	1 July 2023
Primary completion	1 July 2024
Estimated completion	31 December 2024

Drugs / interventions tested

tunneled PICC
routine PICC

Conditions studied

Cancer — all drugs for Cancer →
Thrombus — all drugs for Thrombus →
Phlebitis — all drugs for Phlebitis →
Infections — all drugs for Infections →

Sponsor

Shandong Branden Med.Device Co.,Ltd

Who can join

18 and older, any sex, with Cancer or Thrombus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, eligible subjects were randomly assigned to the experimental or control group through randomization (1:1). Under the guidance of electrocardiographic Doppler ultrasound guided puncture and catheterization (EDUG) technology, the tunnel puncture method was compared with the conventional puncture method. The two groups of patients were observed and evaluated intraoperative and postoperative 7 ± 3 days, 30 ± 7 days, 60 ± 10 days, and 90 ± 10 days 120 ± 10 days (if any) and the occurrence of complications during extubation or unplanned extubation at the end of treatment, comparing cases in the north and south, as well as complications related to different catheterization methods

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of tunneled PICC

Trials testing the same drug.

NCT05629195 — The Effect of Skin Laxity on the PICC · NA · unknown

Other recruiting trials for Cancer

Currently open trials in the same condition.

NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting

Other Shandong Branden Med.Device Co.,Ltd trials

Trials by the same sponsor.

NCT05621473 — Comparing the Safety and Effectiveness of Tunnel PICC Guided by EDUG and Conventional PICC · NA · unknown
NCT05555160 — Application of Intracavity Electrocardiogram Positioning Technique in PICC · NA · unknown
NCT05477940 — Study on Absorbable Zinc Alloy Drug Eluting Coronary Stent System · NA · unknown
NCT05676164 — A Study to Evaluate the Safety and Efficacy of Oral Contrast Agent for Sonography · NA · completed
NCT05651217 — Clinical Study on Disposable Sterile Urinary Catheter · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05870449 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shandong Branden Med.Device Co.,Ltd
Last refreshed: 23 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05870449.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing